Nirmatrelvir–ritonavir (NMV/r) is now being used to treat high-risk patients with mild to moderate COVID-19. This article provides advice to clinicians regarding recognition of medications likely to interact with NMV/r and suggests approaches to managing such drug–drug interactions. An algorithm is provided to assist in decision making.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890619 | PMC |
| http://dx.doi.org/10.7326/M22-0281 | DOI Listing |
Publication Analysis
Top Keywords
prescribing nirmatrelvir-ritonavir
4
nirmatrelvir-ritonavir recognize
4
recognize manage
4
manage drug-drug
4
drug-drug interactions
4
interactions nirmatrelvir–ritonavir
4
nirmatrelvir–ritonavir nmv/r
4
nmv/r treat
4
treat high-risk
4
high-risk patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!